April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Retinal Nerve Fiber Layer (RNFL) Thickness Analysis in Sickle Cell Disease: Implications for Glaucoma Evaluation
Author Affiliations & Notes
  • Rohan J. Shah
    UIC Department of Ophthalmology, University of Illinois-Chicago, Chicago, Illinois
  • Clement C. Chow
    UIC Department of Ophthalmology, University of Illinois-Chicago, Chicago, Illinois
  • Joelle A. Hallak
    UIC Department of Ophthalmology, University of Illinois-Chicago, Chicago, Illinois
  • Jennifer I. Lim
    UIC Department of Ophthalmology, University of Illinois-Chicago, Chicago, Illinois
  • Thasarat S. Vajaranant
    UIC Department of Ophthalmology, University of Illinois-Chicago, Chicago, Illinois
  • Footnotes
    Commercial Relationships  Rohan J. Shah, None; Clement C. Chow, llinois Society for the Prevention of Blindness Seed Grant (F); Joelle A. Hallak, None; Jennifer I. Lim, None; Thasarat S. Vajaranant, None
  • Footnotes
    Support  Illinois Society for the Prevention of Blindness Seed Grant
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 248. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rohan J. Shah, Clement C. Chow, Joelle A. Hallak, Jennifer I. Lim, Thasarat S. Vajaranant; Retinal Nerve Fiber Layer (RNFL) Thickness Analysis in Sickle Cell Disease: Implications for Glaucoma Evaluation. Invest. Ophthalmol. Vis. Sci. 2011;52(14):248.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Studies have shown that patients with sickle cell hemoglobinopathies (SCH) have focal macular thinning in over 50% of eyes. However, knowledge about peripapillary RNFL changes in SCH is limited. The aim of this study is to determine whether sickle cell patients have RNFL thickness abnormalities, which could impact glaucoma evaluations.

Methods: : In this prospective study, SCH (SS, SC, and S-Thalassemia) patients and age similar, race-matched controls underwent SDOCT of the macula and optic nerve head (ONH) using the Heidelberg Spectralis. Patients with prior retinal treatments (laser or surgery), diabetes mellitus, or other ocular diseases were excluded. RNFL thickness measurements within each of the 7 subfields of the ONH as displayed on the SDOCT report were recorded. The sickle patients were further grouped into those with focal macular thinning (Group 1) and those without (Group 2). ANOVA testing and post hoc analysis with the Tukey test were performed to assess for RNFL thickness differences among Group 1, Group 2 and controls.

Results: : SDOCT images from 73 eyes of 42 sickle cell patients and 24 eyes of 13 control patients were analyzed. Of the 73 eyes from sickle cell patients, 31 represented Group 1 and 42 represented Group 2. Mean ages among each group were not statistically different (p = 0.28). Mean RNFL thicknesses were significantly different among the 3 groups in 4 of 7 (57%) ONH subfields. Group 1 had significantly thinner RNFL in the nasal, (66 vs. 85 µm, p=.0001), inferotemporal (140 vs. 157 µm, p=.0206), superonasal (105 vs. 123 µm, p=.0388), and central (95 vs. 109 µm, p=.0005) ONH subfields when compared with controls; and significantly thinner RNFL in the nasal (66 vs. 76 µm, p = .0293) and central (95 vs. 103 µm, p = .0179) ONH subfields when compared with Group 2. There were no significant differences in any ONH subfields between Group 2 and controls.

Conclusions: : Sickle cell patients with focal macular thinning on SDOCT have significantly thinner RNFL on SDOCT than those without macular thinning and controls. These patients may require different RNFL thickness thresholds for future glaucoma evaluations. Further studies using perimetry will help determine whether these RNFL changes are visually significant and whether they would affect glaucoma evaluations.

Keywords: nerve fiber layer • retina • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×